Leading global pharmaceutical products and respective revenues 2024

Keytruda, a pharmaceutical product owned by Merck & Co, is forecast to generate some 17 billion U.S. dollars in revenue in 2024. Other pharmaceutical products, such as Humira, Eliquis, and Opdivo, are also expected to do well that year.

Biotech companies

In 2019, Amgen was the world’s top pure play biotech company, based on market capitalization. The American company had a total market cap of almost 130 billion U.S. dollars that year. In terms of R&D expenditure, the Swiss company, by the name of Roche, led the 2018 rankings, spending over 11 billion U.S. dollars. Celgene and Gilead Sciences stood in second and third place respectively and spent a total of just under 11 billion U.S. dollars on research and development combined that year.

Gilead Sciences

Gilead Sciences, which is headquartered in California, United States, generated over 22 billion U.S. dollars of revenue in 2018. Gilead Sciences’ top product was Genvoya, which made about 21 percent of the company’s total revenue in 2018. Genvoya is a prescription medicine used to treat HIV-1.

Projected top 10 global pharmaceutical products by revenue in 2024

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

$39 $59 per month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2019

Region

Worldwide

Survey time period

as of May 2019

Supplementary notes

Sales represent company reported sales where available, otherwise based on an average of equity analyst estimates.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.